The self-reported personal wellbeing of a sample of Australian injecting drug users

Addiction

Volumn 105, Issue 12, 2010, Pages 2141-2148

  Dietze, Paul ^a,b   Stoové, Mark ^a   Miller, Peter ^c   Kinner, Stuart ^a,d   Bruno, Raimondo ^e   Alati, Rosa ^d   Burns, Lucy ^f  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Heroin use; Injecting drug use; Personal wellbeing index

Indexed keywords

DIAMORPHINE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; AUSTRALIA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH DISPARITY; HUMAN; INTOXICATION; MALE; MENTAL DISEASE; MIDDLE AGED; NOTE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELF REPORT; SOCIOECONOMICS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS DISPARITIES; HEROIN; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OVERDOSE; PATIENT SATISFACTION; QUALITY OF LIFE; SELF REPORT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 78249264761     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03090.x     Document Type: Article

References (34)

1. Dalgard O., Egeland A., Skaug K., Vilimas K., Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004; 39: 74-80.
2. Marcellin F., Preau M., Ravaux I., Dellamonica P., Spire B., Carrieri M. P. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007; 8: 320-7.
3. Temple-Smith M., Stoové M. A., Smith A., O'Brien M. L., Mitchell D., Banwell C. et al. Gender differences in seeking care for hepatitis C: the Australian experience. J Subst Use 2007; 12: 59-70.
4. Puigdollers E., Domingo-Salvany A., Brugal M. T., Torrens M., Alvaros J., Castillo C. et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 2004; 39: 1353-68.
5. Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997; 92: 707-16.
6. Snow K., Kosinski M., Gandek B., Ware J. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: Health Institute, New England Medical Centre; 1993.
7. Cummins R. A. Objective and subjective quality of life: an interactive model. Soc Indic Res 2000; 52: 55.
8. Cummins R. A., Lau A. L. D., Stokes M. HRQOL and subjective well-being: noncomplementary forms of outcome measurement. Expert Rev Pharmacoeconomics Outcomes Res 2004; 4: 413-20.
9. Curran L., Wolman H., Hill E., Furdell K. Economic wellbeing and where we live: accounting for geographical cost-of-living differences in the US. Urban Stud 2006; 43: 2443.
10. WHOQOL. The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
11. International Wellbeing Group. Personal Wellbeing Index: 4th edition. Melbourne, Vic: Australian Centre on Quality of Life, Deakin University; 2006.
12. Cummins R. A. Measuring health and subjective wellbeing: vale, quality-adjusted life-years. In: Manderson L., editor. Rethinking Wellbeing. Perth, WA: Australian Research Institute, Curtin University of Technology; 2005, p. 69-90.
13. Russell J. Core affect and the psychological construction of emotion. Psychol Rev 2003; 110: 145-72.
14. Michalos A. Social indicators research and health-related quality of life research. Soc Indic Res 2004; 65: 27-72.
15. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992; 87: 733-42.
16. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357: 7-8.
17. Covinsky K. E., Wu A. W., Landefeld C. S., Connors A. F. Jr, Phillips R. S., Tsevat J. et al. Health status versus quality of life in older patients: does the distinction matter? Am J Med 1999; 106: 435-40.
18. Smith K. W., Avis N. E., Assmann S. F. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res 1999; 8: 447-59.
19. Brogly S., Mercier C., Bruneau J., Palepu A., Franco E. Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Subst Use Misuse 2003; 38: 965-92.
20. Hubley A. M., Russell L. B., Palepu A. Injection Drug Use Quality of Life scale (IDUQOL): a validation study. Health Qual Life Outcomes 2005; 3: 43.
21. Hubley A. M., Palepu A. Injection Drug User Quality of Life Scale (IDUQOL): findings from a content validation study. Health Qual Life Outcomes 2007; 5: 46.
22. Russell L. B., Hubley A. M. Importance ratings and weighting: old concerns and new perspectives. Int J Testing 2005; 5: 105-30.
23. Trauer T., MacKinnon A. Why are we weighting? The role of importance ratings in quality of life measurement. Qual Life Res 2001; 10: 579-85.
24. Kinner S. A., George J., Campbell G., Degenhardt L. Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia. Aust NZ J Public Health 2009; 33: 223-7.
25. Hando J., Darke S., O'Brien S., Maher L., Hall W. The development of an early warning system to detect trends in illicit drug use in Australia-the illicit drug reporting system. Addict Res 1998; 6: 97-113.
26. Cummins R. A., Woerner J., Gibson A., Weinberg M., Collard J., Chester M. Australian Unity Wellbeing Index, Survey 21. Burwood, Vic: Australian Centre on Quality of Life; 2009.
27. Cummins R. A., Nistico H. Maintaining life satisfaction: the role of positive cognitive bias. J Happiness Stud 2002; 3: 37-69.
28. Cummins R. A. Australian Unity Wellbeing Index. Melbourne, Vic: Deakin University; 2003.
29. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J. et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007; 87: 39-45.
30. Lawrinson P., Ali R., Buavirat A., Chiamwongpaet S., Dvoryak S., Habrat B. et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008; 103: 1484-92.
31. Dietze P., Jolley D., Fry C., Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction 2005; 100: 636-42.
32. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: causes and consequences. Addiction 2001; 96: 1113-25.
33. Topp L., Iversen J., Wand H., Day C., Kaldor J., Maher L. Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr 2008; 47: 632-8.
34. Topp L., Day C., Dore G. J., Maher L. Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review. Drug Alcohol Rev 2009; 28: 669-75.